EUVIMEDEUVIMED entdecken
Crossref

Antithrombotic Effect of a Bivalent DNA Aptamer of Thrombin

Yanxi Chen, Shoubo Xiang iD, Chunfa Chen, Qiuyu Su, Zhe Zhang iD, Yangyang Fan, Zhihong Cui, Lixue Yin, Hua Zuo iD, Mingliang Zuo

ACS Biomaterials Science & Engineering · 2025

DOI: 10.1021/acsbiomaterials.5c00222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2025. Verfasst von Yanxi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Thrombin, Fibrinolytic Agents, Thrombosis. Die Arbeit nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Provincial People?s Hospital, Natural Science Foundation of Chongqing, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombin plays a critical role in both coagulation and platelet activation, and its interaction with thrombin-protease-activated receptor 1 (PAR1) on platelets and vascular smooth muscle cells (VSMCs) leads to a series of pathological processes such as thrombosis, restenosis, and atherosclerosis. This study investigated the antithrombotic properties of a bivalent DNA aptamer (bApt) with phosphorothioate backbone modification designed to inhibit thrombin, with a specific focus on its ability to regulate the thrombin-PAR1 signaling pathway. The results showed that bApt modulated the thrombin-PAR1 pathway, effectively reduced thrombus formation, platelet aggregation, and VSMC proliferation. Key findings from the study highlight that bApt successfully prolonged coagulation reaction time (R value), coagulation time (K value), maximum amplitude (MA) and reduced coagulation angle (α value), and also prolonged thrombin time (TT) and activated partial thromboplastin time (APTT), in a dose-dependent manner. Moreover, in an arterial injury model, bApt reduced thrombus formation significantly, supporting its potential as a therapeutic agent for thrombotic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideThrombinFibrinolytic AgentsThrombosisAnimalsPlatelet AggregationHumansBlood CoagulationMyocytes, Smooth MuscleMuscle, Smooth, VascularMaleCell ProliferationReceptor, PAR-1

Stichwörter der Autor:innen

DNA aptamerPAR1atherosclerosisbivalentthrombin inhibitor

Substanzen

Aptamers, NucleotideThrombinFibrinolytic AgentsReceptor, PAR-1thrombin aptamer

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
  • Ultrasound in Cardiac Electrophysiology and Biomechanics Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cardiovascular Disease, Sichuan Provincial People's Hospital, University of Electronic Sc…
  • Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.

ORCID-Profile: Shoubo Xiang, Zhe Zhang, Hua Zuo

Förderung

  • National Natural Science Foundation of China
  • Sichuan Provincial People?s Hospital
  • Natural Science Foundation of Chongqing, China

Zitieren

APA

Chen, Y., Xiang, S., Chen, C., Su, Q., Zhang, Z., Fan, Y., Cui, Z., Yin, L., Zuo, H., & Zuo, M. (2025). Antithrombotic Effect of a Bivalent DNA Aptamer of Thrombin. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c00222

Vancouver

Chen Y, Xiang S, Chen C, Su Q, Zhang Z, Fan Y, et al. Antithrombotic Effect of a Bivalent DNA Aptamer of Thrombin. ACS Biomaterials Science & Engineering. 2025. doi:10.1021/acsbiomaterials.5c00222

BibTeX
@article{Chen2025,
  author = {Chen, Yanxi and Xiang, Shoubo and Chen, Chunfa and Su, Qiuyu and Zhang, Zhe and Fan, Yangyang and Cui, Zhihong and Yin, Lixue and Zuo, Hua and Zuo, Mingliang},
  title = {Antithrombotic Effect of a Bivalent DNA Aptamer of Thrombin},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2025},
  doi = {10.1021/acsbiomaterials.5c00222}
}
Kostenlos starten →